Two-hybrid screening of FAM13A protein partners in lung epithelial cells - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue BMC Research Notes Année : 2020

Two-hybrid screening of FAM13A protein partners in lung epithelial cells

Résumé

OBJECTIVES: Family with sequence similarity 13 member A (FAM13A) genetic variants have been associated with several chronic respiratory diseases including chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), idiopathic pulmonary fibrosis (IPF) and lung cancer. The FAM13A protein includes a RhoGTPase activating protein (RhoGAP) domain known to participate in various cellular mechanisms including cell proliferation. While intensive genomic studies have been performed to reveal its involvement in lung diseases, the biological role of FAM13A protein is still not completely elucidated. RESULTS: We therefore performed a two-hybrid screening to identify protein partners of FAM13A using a human lung cancer cDNA library. We identified several protein partners with a high confidence score. Researchers in the field of chronic lung diseases may benefit from this two-hybrid screening data which may reveal new research pathways to decipher.
Fichier principal
Vignette du fichier
s13104-019-4840-9.pdf (2.25 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

inserm-02512324 , version 1 (19-03-2020)

Identifiants

Citer

Manon Ruffin, Kristin E Thompson, Harriet Corvol, Loïc Guillot. Two-hybrid screening of FAM13A protein partners in lung epithelial cells. BMC Research Notes, 2020, 12 (1), pp.804. ⟨10.1186/s13104-019-4840-9⟩. ⟨inserm-02512324⟩
69 Consultations
43 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More